Second-generation inhibitors of Bruton tyrosine kinase
Bruton tyrosine kinase (BTK) is a critical effector molecule for B cell development and plays a major role in lymphoma genesis. Ibrutinib is the first-generation BTK inhibitor. Ibrutinib has off-target effects on EGFR, ITK, and Tec family kinases, which explains the untoward effects of ibrutinib. Re...
Main Authors: | Wu, Jingjing, Liu, Christina, Tsui, Stella T., Liu, Delong |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010774/ |
Similar Items
-
Novel Bruton’s tyrosine kinase inhibitors currently in development
by: D’Cruz, Osmond J, et al.
Published: (2013) -
Bruton's tyrosine kinase: oncotarget in myeloma
by: Tai, Yu-Tzu, et al.
Published: (2012) -
Single cell imaging of Bruton's Tyrosine Kinase using an irreversible inhibitor
by: Turetsky, Anna, et al.
Published: (2014) -
Regulatory Phosphorylation of Ikaros by Bruton's Tyrosine Kinase
by: Ma, Hong, et al.
Published: (2013) -
Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
by: Ng, Yen-Shing, et al.
Published: (2004)